Abstract
Cancer is one of the world’s most serious non-communicable diseases, and it has become one of the leading causes of morbidity and mortality. According to the American Cancer Society’s projections (2022), approximately 28.0 million new cancer cases and 16.2 million cancer-related deaths are expected to be reported by 2040. It is imperative to focus more on developing new technologies and pharmacological compounds to treat these cancers. Despite tremendous improvements in cancer prevention and treatment over the past few years, the mortality rate is still too high. Current chemotherapy treatments are frequently constrained by unforeseen adverse effects or developed resistance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
